Literature DB >> 31455334

Correction to: The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs.

Chao-Jie Wang1, Chun-Chao Zhu1, Jia Xu1, Ming Wang1, Wen-Yi Zhao1, Qiang Liu1, Gang Zhao2, Zi-Zhen Zhang3.   

Abstract

Following publication of the original article [1], authors reported Pro. Gang Zhao has to be considered as another corresponding author, according to his important contribution.

Entities:  

Year:  2019        PMID: 31455334      PMCID: PMC6710865          DOI: 10.1186/s12943-019-1059-2

Source DB:  PubMed          Journal:  Mol Cancer        ISSN: 1476-4598            Impact factor:   27.401


Correction to: Mol Cancer https://doi.org/10.1186/s12943-019-1032-0 Following publication of the original article [1], authors reported Pro. Gang Zhao has to be considered as another corresponding author, according to his important contribution. In the original submission, Pro. Gang Zhao has been already listed as a joint corresponding author. But there was a mistake about author list in the proof process. About the formal author list, please see above author group section.
  1 in total

1.  The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs.

Authors:  Chao-Jie Wang; Chun-Chao Zhu; Jia Xu; Ming Wang; Wen-Yi Zhao; Qiang Liu; Gang Zhao; Zi-Zhen Zhang
Journal:  Mol Cancer       Date:  2019-07-04       Impact factor: 27.401

  1 in total
  8 in total

1.  Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis.

Authors:  Qingyang Meng; Xiangjun Wang; Tongqing Xue; Qiangfang Zhao; Wei Wang; Kun Zhao
Journal:  Cancer Cell Int       Date:  2020-08-27       Impact factor: 5.722

2.  LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2).

Authors:  Hongchao Yao; Like Yang; Linli Tian; Yan Guo; Yushan Li
Journal:  Cancer Cell Int       Date:  2020-04-28       Impact factor: 5.722

3.  LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.

Authors:  Xiaoliu Du; Yiming Tu; Shuang Liu; Pengzhan Zhao; Zhongyuan Bao; Chong Li; Jinhao Li; Minhong Pan; Jing Ji
Journal:  J Cell Mol Med       Date:  2019-12-19       Impact factor: 5.310

4.  Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/β-catenin signalling pathway and is a potential diagnostic biomarker.

Authors:  Ning Li; Juan Li; Qi Mi; Yan Xie; Peilong Li; Lili Wang; Helen Binang; Qing Wang; Yanlei Wang; Yingjie Chen; Yunshan Wang; Haiting Mao; Lutao Du; Chuanxin Wang
Journal:  J Cell Mol Med       Date:  2020-09-05       Impact factor: 5.310

5.  miR‑106b‑5p targeting SIX1 inhibits TGF‑β1‑induced pulmonary fibrosis and epithelial‑mesenchymal transition in asthma through regulation of E2F1.

Authors:  Shuang Liu; Xi Chen; Siqing Zhang; Xinyu Wang; Xiaoliu Du; Jiahe Chen; Guoping Zhou
Journal:  Int J Mol Med       Date:  2021-01-26       Impact factor: 4.101

Review 6.  Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications.

Authors:  Huidan Tan; Shouyue Zhang; Jin Zhang; Lingjuan Zhu; Yanmei Chen; Hongmei Yang; Yi Chen; Yang An; Bo Liu
Journal:  Theranostics       Date:  2020-07-11       Impact factor: 11.556

7.  A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.

Authors:  Kai Zhang; Lei Zhang; Yang Mi; YouCai Tang; FeiFei Ren; Bin Liu; Yi Zhang; PengYuan Zheng
Journal:  Cancer Sci       Date:  2020-09-11       Impact factor: 6.716

8.  MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.

Authors:  Cheng-You Jia; Wei Xiang; Ji-Bin Liu; Geng-Xi Jiang; Feng Sun; Jian-Jun Wu; Xiao-Li Yang; Rui Xin; Yi Shi; Dan-Dan Zhang; Wen Li; Zavuga Zuberi; Jie Zhang; Gai-Xia Lu; Hui-Min Wang; Pei-Yao Wang; Fei Yu; Zhong-Wei Lv; Yu-Shui Ma; Da Fu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.